Journal of Neurology

, Volume 243, Supplement 1, pp S1–S2 | Cite as


  • Kenneth P. Johnson


  1. 1.
    Bornstein MB, Miller AI, Teitelbaum D, et al (1982) Multiple sclerosis: trial of a synthetic polypeptide. Ann Neurol 11: 317–319CrossRefPubMedGoogle Scholar
  2. 2.
    Bornstein MB, Miller A, Slagle S, et al (1987) A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317:408–414PubMedCrossRefGoogle Scholar
  3. 3.
    Bornstein MB, Miller A, Slagle S, et al (1991) A placebo-controlled, doubleblind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology 41:533–539PubMedGoogle Scholar
  4. 4.
    Johnson KP, Brooks BR, Cohen JA, et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 45:1268–1276PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • Kenneth P. Johnson
    • 1
  1. 1.University of MarylandBaltimoreUSA

Personalised recommendations